EGFR and non-small cell lung carcinoma: Furthermore, since ERCC1 endonuclease acted not only in ICL repair but also played a role in completion of HR following ICL repair,26 we considered that NSCLC cells with EGFR exon 19 deletion might be HR deficient and sensitive to PARP inhibitor.